You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Follicular Dendritic Cell Saroma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

Suspended
  • Lymphoma
  • +3 more
  • Chicago, Illinois
  • +3 more
Jan 30, 2023

Aggressive Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Recurrent DLBCL Trial in Rochester (procedure, biological,

Active, not recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +9 more
  • Cryosurgery
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

Patients Previously Treated WithMustang Bio CAR-T Cell

Enrolling by invitation
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • +10 more
  • Prior MB-102 CAR-T cell investigational product.
  • Prior MB-106 CAR-T cell investigational product.
  • Duarte, California
  • +4 more
Dec 8, 2022

Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Rochester (biological, procedure,

Completed
  • Cutaneous B-cell Non-Hodgkin Lymphoma
  • +15 more
  • dendritic cell vaccine therapy
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 13, 2020

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Melanoma Trial in New York (Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs))

Completed
  • Melanoma
  • Langerhans-type dendritic cells (a.k.a. Langerhans cells or LCs)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2023

Multiple Myeloma Trial in Boston (Nivolumab, DC/myeloma fusions/GM-CSF)

Terminated
Has Results
  • Multiple Myeloma
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Sep 28, 2022

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))

Active, not recruiting
Has Results
  • Renal Cancer
  • Dendritic Cell Tumor Fusion Vaccine
  • Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 2, 2023

Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Los Angeles (Autologous

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +3 more
  • Autologous Dendritic Cell-Adenovirus CCL21 Vaccine
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 21, 2022

Obinutuzumab in Chinese Real-world Patients With iNHL

Not yet recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Changzhou, Jiangsu, China
  • +24 more
Jul 23, 2023

Ovarian Cancer Trial in Seoul (Cellgram-DC)

Terminated
  • Ovarian Cancer
  • Cellgram-DC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell

Not yet recruiting
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid System Neoplasm
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 16, 2022

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell (DC1) Vaccine, Trastuzumab, Pepinemab)

Recruiting
  • HER2-positive Breast Cancer
  • Dendritic Cell (DC1) Vaccine
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 28, 2022

NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Dendritic cell immunotherapy
  • +2 more
  • Ghent, Belgium
    Ghent University Hospital
Dec 23, 2022

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Refractory Leukemia, Relapsed Leukemia, Acute Myelogenous Leukemia Trial in Miami (STING-Dependent Activators (STAVs) Loaded

Not yet recruiting
  • Refractory Leukemia
  • +4 more
  • STING-Dependent Activators (STAVs) Loaded Autologous Leukemic Cells
  • Dendritic Cell Vaccine
  • Miami, Florida
    University of Miami
Jan 23, 2023

Melanoma Trial in Philadelphia (Mature dendritic cell (DC) vaccine, Cyclophosphamide 300mg/m^2, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • Mature dendritic cell (DC) vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 2, 2023

Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)

Recruiting
  • Acute Myelogenous Leukemia
  • DC/AML Fusion Vaccine
  • Observation
  • Atlanta, Georgia
  • +4 more
Apr 14, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023